Laura founded Vivan Therapeutics in 2018 to advance a ground breaking personalised approach to cancer developed at Mt Sinai Medical Center and is the current CEO. Laura became passionate about personalised medicine during her PhD studies at Weill Cornell Graduate School for Medical Sciences/Memorial Sloan Kettering Cancer Center. Since then she has been actively involved in translational advances in medicine. In 2008 she co-founded Celmatix, and was the founding CEO, and helped build a next-generation women’s health company leveraging big-data and genomics. Laura is an avid startup and technology strategist and angel investor, with a focus on personalised medicine. Laura is driven to help develop and foster biotechnology communities globally, and is an active advisor, speaker and mentor.